Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2026
DNA Replication Errors Drive Genome-Wide Small Inverted Triplication DynamicsYi Lei, Yu Zhou, Haitao Sun, et al.Science China. Life Sciences|October 20, 2021
LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathyQi Zhang, Danyang Li, Xue Dong, et al.Nucleic Acids Research|October 29, 2024
EGFR-mediated HSP70 phosphorylation facilitates PCNA association with chromatin and DNA replicationYingying Wang, Anthony Fernandez, Xinyu Pei, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 8, 2023
MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modificationYuting Zhuang, Tingting Li, Xiaoxi Hu, et al.Nature Biomedical Engineering|October 1, 2025
Targeted clearance of extracellular Tau using aptamer-armed monocytes alleviates neuroinflammation in mice with Alzheimer's diseaseYuting Zhuo, Yao Lu, Yan Zhu, et al.Circulation Research|February 2, 2022
CIRKIL Exacerbates Cardiac Ischemia/Reperfusion Injury by Interacting With Ku70Hongwen Xiao, Mingyu Zhang, Hao Wu, et al.ACS Chemical Biology|May 16, 2025
Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer TherapyYixing Wang, Jessica D Hess, Chen Wang, et al.Cell Chemical Biology|July 13, 2023
Substrate-dependent interaction of SPOP and RACK1 aggravates cardiac fibrosis following myocardial infarctionWanqi Yang, Yuting Zhuang, Hao Wu, et al.Iscience|June 13, 2024
Microglial apolipoprotein E particles contribute to neuronal senescence and synaptotoxicityNa Wang, Lujian Cai, Xinyu Pei, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
Milademetan in advanced solid tumors with MDM2 amplification and wild-type TP53: pre-clinical and phase 2 clinical trial resultsEcaterina E Dumbrava, Thomas E Stinchcombe, Mrinal Gounder, et al.Pageof 3